JP2025505696A5 - - Google Patents

Info

Publication number
JP2025505696A5
JP2025505696A5 JP2024547315A JP2024547315A JP2025505696A5 JP 2025505696 A5 JP2025505696 A5 JP 2025505696A5 JP 2024547315 A JP2024547315 A JP 2024547315A JP 2024547315 A JP2024547315 A JP 2024547315A JP 2025505696 A5 JP2025505696 A5 JP 2025505696A5
Authority
JP
Japan
Prior art keywords
sequence number
optionally
washing buffer
protein
buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024547315A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025505696A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/062322 external-priority patent/WO2023154822A2/en
Publication of JP2025505696A publication Critical patent/JP2025505696A/ja
Publication of JP2025505696A5 publication Critical patent/JP2025505696A5/ja
Pending legal-status Critical Current

Links

JP2024547315A 2022-02-10 2023-02-09 生産物の精製方法 Pending JP2025505696A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263267810P 2022-02-10 2022-02-10
US63/267,810 2022-02-10
PCT/US2023/062322 WO2023154822A2 (en) 2022-02-10 2023-02-09 Methods of purifying a product

Publications (2)

Publication Number Publication Date
JP2025505696A JP2025505696A (ja) 2025-02-28
JP2025505696A5 true JP2025505696A5 (cg-RX-API-DMAC7.html) 2026-02-12

Family

ID=87521638

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024547315A Pending JP2025505696A (ja) 2022-02-10 2023-02-09 生産物の精製方法

Country Status (10)

Country Link
US (1) US20230250133A1 (cg-RX-API-DMAC7.html)
EP (1) EP4476237A2 (cg-RX-API-DMAC7.html)
JP (1) JP2025505696A (cg-RX-API-DMAC7.html)
KR (1) KR20240142564A (cg-RX-API-DMAC7.html)
CN (1) CN119032099A (cg-RX-API-DMAC7.html)
AU (1) AU2023217074A1 (cg-RX-API-DMAC7.html)
CA (1) CA3251000A1 (cg-RX-API-DMAC7.html)
IL (1) IL314472A (cg-RX-API-DMAC7.html)
MX (1) MX2024009755A (cg-RX-API-DMAC7.html)
WO (1) WO2023154822A2 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2819217T3 (es) 2013-09-08 2021-04-15 Kodiak Sciences Inc Conjugados de polímeros iónicos dipolares y factor VIII
CA3059938A1 (en) 2017-04-14 2018-10-18 Kodiak Sciences Inc. Complement factor d antagonist antibodies and conjugates thereof
CA3092588A1 (en) 2018-03-02 2019-09-06 Kodiak Sciences Inc. Il-6 antibodies and fusion constructs and conjugates thereof
CA3157509A1 (en) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Methods of treating an eye disorder
AU2021377336A1 (en) * 2020-11-16 2023-07-06 Prothera Biologics, Inc. Methods for purifying inter-alpha inhibitor proteins
EP4788450A1 (en) * 2023-10-04 2026-08-12 Sartorius BIA Separations d.o.o. Enhanced chromatographic separations of components in a mixture by employing chaotropic elution
WO2025184423A1 (en) * 2024-02-29 2025-09-04 Kodiak Sciences Inc. Cell-surface-targeting-domain-polymer-payload conjugate
US20260070966A1 (en) * 2024-09-06 2026-03-12 Eyebiotech Limited Multivalent fzd4, wnt co-receptor, and vegf receptor molecules and uses thereof
US20260092125A1 (en) * 2024-09-06 2026-04-02 Eyebiotech Limited Multivalent fzd4, wnt co-receptor, and vegf binding molecules and uses thereof
WO2026075981A1 (en) * 2024-10-01 2026-04-09 Regeneron Pharmaceuticals, Inc. Methods of analyzing heterodimeric proteins
CN119454939A (zh) * 2024-11-28 2025-02-18 北海康成(苏州)生物制药有限公司 一种欧莫扑拜单抗原液及其制备方法
CN119524125A (zh) * 2024-11-28 2025-02-28 北海康成(苏州)生物制药有限公司 一种欧莫扑拜单抗原液的生产方法及欧莫扑拜单抗原液

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045314B2 (en) * 2000-04-04 2006-05-16 Baxter International Inc. Method for the production of bacterial toxins
CN102395597A (zh) * 2009-03-11 2012-03-28 惠氏有限责任公司 纯化小模块免疫药物蛋白的方法
CA2853358A1 (en) * 2011-10-24 2013-05-02 Halozyme, Inc. Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
WO2015101586A1 (en) * 2014-01-03 2015-07-09 F. Hoffmann-La Roche Ag Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles
CN110981957B (zh) * 2014-01-15 2024-12-24 豪夫迈·罗氏有限公司 具有改善的蛋白A结合作用的Fc区变体
EP3054007A1 (en) * 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
JP6959912B2 (ja) * 2015-09-23 2021-11-05 ジェネンテック, インコーポレイテッド 抗vegf抗体の最適化変異体
IL290457B2 (en) * 2015-12-30 2025-02-01 Kodiak Sciences Inc Antibodies and their conjugates
CA3092588A1 (en) * 2018-03-02 2019-09-06 Kodiak Sciences Inc. Il-6 antibodies and fusion constructs and conjugates thereof
US20210254073A1 (en) * 2020-02-04 2021-08-19 Cornell University Methods for capture and analysis of macromolecular complexes

Similar Documents

Publication Publication Date Title
KR101921767B1 (ko) 단백질 정제
AU2014300486B2 (en) Purification process for monoclonal antibodies
RU2558367C2 (ru) Способ очистки полипептидных растворов
JP7187436B2 (ja) アフィニティークロマトグラフィー洗浄バッファー
JP2024059888A5 (cg-RX-API-DMAC7.html)
JP2012507557A5 (cg-RX-API-DMAC7.html)
JP2016523812A (ja) タンパク質のピログルタミン酸形成を増加させるための方法
RU2011137030A (ru) Способы очистки малых модулярных иммунофармацевтических белков
JPH0797997B2 (ja) 新規生理活性ポリペプチド
CN113416243B (zh) 一种纯化抗体的方法
JP2022518282A5 (cg-RX-API-DMAC7.html)
US20230143163A1 (en) Protein a chromatography purification of an antibody
TWI911155B (zh) 藉由多肽鏈交換活化之治療性多特異性多肽
CN117866103A (zh) 一种抗破伤风双特异性抗体及其制备方法与应用
CN113166200A (zh) 一种提高蛋白a层析法去除聚集体的方法
JP2025509722A5 (cg-RX-API-DMAC7.html)
AU2013314264B2 (en) Method for the production of polypeptides in the periplasm of prokaryotic cells
CN114621354A (zh) Fab-白蛋白结合肽融合蛋白及其制备方法和应用
JP2024513835A5 (cg-RX-API-DMAC7.html)
JP2022554283A5 (cg-RX-API-DMAC7.html)
CN114539416A (zh) 一种双特异性抗体的层析纯化工艺
EP4696709A1 (en) Variants of etanercept and related processes
CN103864916B (zh) 人胸腺肽β4三倍体蛋白、编码基因及其分离纯化方法
WO2016103139A1 (en) Method for reduction of aggregates
CN120965862A (zh) 一种NbES9单域抗体、NbES9-TAT融合单域抗体及其用途